Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Blood & Tissue Safety: Geographic Areas with Zika Virus Transmission Risk

Zika virus information for blood collection and tissue recovery organizations

CDC is working with state health departments and blood and tissue recovery organizations to help ensure the safety of our blood and tissue supply and reduce the risk of Zika virus transmission through blood transfusion and tissue transplants. Zika virus disease is a nationally notifiable condition. Cases are reported to CDC by state and local health departments using standard case definitions.

Areas of Active Zika Virus Transmission Risk in the United States

To protect the US blood and tissue supply, CDC in collaboration with the US Food and Drug Administration (FDA), defines areas of active Zika virus transmission based on the designation of Zika cautionary (yellow) areas. These defined areas of risk can be different from areas for which CDC has issued travel guidance. For the purposes of blood and tissue safety intervention, areas of active Zika virus transmission will be defined at the county-level.

Previously listed areas of active Zika virus transmission risk  in the continental United States for the purposes of blood and tissue safety intervention:

  • Cameron County, Texas – From December 9, 2016 – August 29, 2017
  • Miami-Dade County, Florida – From July 29, 2016 – June 2, 2017
  • Palm Beach County, Florida – From August 24, 2016 – November 2, 2016

Travel notice posting dates for countries and territories with reported local mosquito transmission of Zika virus

Country or Territory Date Travel Notification Posted
American Samoa 2/1/2016 – 4/19/2017
Angola 3/10/2017
Anguilla 6/29/2016
Antigua & Barbuda 8/3/2016
Argentina 5/26/2016
Aruba 2/18/2016
Bahamas 8/23/2016
Barbados 1/26/2016
Belize 4/18/2016
Bolivia 1/22/2016
Bonaire 2/18/2016
Brazil 6/9/2015
British Virgin Islands 8/30/2016
Cape Verde 1/26/2016
Cayman Islands 8/11/2016
Colombia 12/10/2015
Costa Rica 2/1/2016
Cuba 3/19/2016
Curacao 2/1/2016
Dominica 3/19/2016
Dominican Republic 1/26/2016
Ecuador 1/22/2016
El Salvador 12/10/2015
Fiji 4/4/2016
French Guiana 12/18/2015
Grenada 5/12/2016
Guadeloupe 1/26/2016
Guatemala 12/10/2015
Guinea-Bissau 3/10/2017
Guyana 1/22/2016
Haiti 1/26/2016
Honduras 2/1/2016
Jamaica 2/3/2016
Kosrae (FSM) 4/1/2016
Maldives 3/10/2017
Marshall Islands 2/23/2016
Martinique 1/26/2016
Mexico 12/10/2015
Micronesia 4/1/2016
Montserrat 11/21/2016
New Caledonia 3/9/2016 – 3/10/2017
Nicaragua 2/1/2016
Palau 11/16/2016
Panama 12/10/2015
Papua New Guinea 4/29/2016
Paraguay 12/10/2015
Peru 5/5/2016
Puerto Rico 12/31/2015
Saba 7/26/2016
Saint Barthelemy 5/9/2016 – 5/26/2017
Saint Lucia 4/11/2016
Saint Martin 1/26/2016
Samoa 2/1/2016
Singapore 8/30/2016
Sint Eustatius 7/14/2016
Sint Maarten 2/29/2016
Solomon Islands 3/10/2017
St. Vincent & the Grenadines 2/29/2016
St. Kitts and Nevis 9/26/2016
Suriname 11/12/2015
The Dominican Republic 1/26/2016
Tonga 2/3/2016
Trinidad & Tobago 2/23/2016
Turks & Caicos 8/3/2016
US Virgin Islands 1/26/2016
Venezuela 12/10/2015

Potential Increased Risk to Blood and Tissue Safety – June 15, 2016 – June 2, 2017

CDC has identified the potential for increased risk to blood and tissue safety in Miami-Dade County starting on June 15, 2016. The potential risk in Miami-Dade County did not meet the threshold for designation as an area of active transmission until July 29, 2016. CDC has also identified that since June 15, 2016, there has been a potential increased risk to blood and tissue safety in Broward and Palm Beach counties because of local travel of residents of these counties to areas of active transmission in Florida.

Guidance for Healthcare Providers Caring for Pregnant Women

FDA: 2017 Safety and Availability Communications